indiamarketoutlook

Aurobindo Pharma : Mirror image trade potential & strategy

indiamarketoutlook 업데이트됨   
NSE:AUROPHARMA   AUROBINDO PHARMA
Aurobindo Pharma
Closing price 648

The chart reflects certain pattern & based on our interpretation, we might see some consolidation in prices for the next month or two.

If Aurobindo Pharma is to replicate a Mirror image pattern then a potential Short strangle strategy may be considered.

Consider selling Aurobindo Pharma

720 Call option around 20

&

580 Put option around 16

Lot size 1000

Max profit potential in strategy Rs 35000/-

Loss in strategy if Aurobindo Pharma closes above 755 or below 545 on 28-May expiry day

----------------------------------------------------------------------------------------------------------------
Cash buying may be considered in 580-615 range
----------------------------------------------------------------------------------------------------------------

Trading in Options involves risk. Understand & do follow risk management measures. Consult your financial advisor.

Take care & safe trading...!!!
액티브 트레이드:
720 call option opened at 21.75 made a high of 22.5 giving us a good price to sell above 20

580 Put option too made a high of 16.40 giving us our price of 16 to sell

Trade is active
액티브 트레이드:
Strategy Update
720 Call option sold @ 21.50 is currently at 17.8

&

580 Put option Sold @ 16 is currently at 9.50

Net so far 1000*( 37.5 - 27.3 ) = Rs 10200/-
액티브 트레이드:
Strategy Update
720 Call option cmp 13.35
580 Put option cmp 4.9

Net so far 1000*( 37.5 -18.25 ) = Rs 19250/-

Enjoy & have a gr8 weekend...!!! :-)
매매 수동청산:
Auro Pharma CMP 668

Strategy Update
Broader market has seen wild swings, yet Aurobindo has been fairly quiet & has stayed within a small range.

720 Call option cmp 10
580 Put option cmp 4.75

Net so far 1000*( 37.5 -14.75 ) = Rs 22750/-

The strategy has worked well & is rewarding a good profit.
Consider to book profits as per your risk appetite

Happy & safe trading...!!!

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.